Today

Agents

Chat

Arena

Discover

More

App

Opaleye Management reports $24,200 purchase of Grace Therapeutics shares - GRCE News | Rallies

Opaleye Management reports $24,200 purchase of Grace Therapeutics shares

GRCE•2026-08-19

Opaleye Management buys Grace Therapeutics shares

Opaleye Management, led by President James Silverman, bought 11,608 Grace Therapeutics common shares at a weighted average of $2.09 per share.
Opaleye’s indirect stake, held through Opaleye, L.P., rose to 2.76 million shares.

Related News

Kratos Receives Multi-Million-Dollar Orders For Gaia 100 Tri-Band Ground Station Systems Through Newly Acquired Orbit

KTOS•2026-08-19

US Stocks-Wall St futures flat after tech rout; Iran tensions, retail earnings in focus

SPY•2026-08-19

SmartKem, Inc. Announces Reverse Split Of Common Stock To Support Continued Nasdaq Listing

Sources

S

Opaleye Management reports $24,200 purchase of Grace Therapeutics shares

Sec

SMTK•2026-08-19

A2Z Cust2mate Secures Follow-On Order For 1,050 Additional Smart Carts From Hastock

AZ•2026-08-19

Cohen & Steers fund manager discloses 2.92% stake in Prologis

PLD•2026-08-19